1Sem.·

Sentiment on Novo Nordisk

$NOVO B (+1,06 %) has been strongly driven by the hype surrounding weight loss injections in recent years, but has also impressed fundamentally with strong EPS growth. After the recent setback, the share price looks attractive again to me.


I see risks above all in the dependence on the US market and the diabetes segment; paradoxically, the company could lose market volume here due to the success of its own products. On the other hand, the potential in the obesity and lifestyle segment remains enormous, and the cash flows enable strong research.


How do you see the current sentiment towards the share, especially in terms of differentiation$LLY (+2,04 %) ?

attachment
6
8 Commentaires

image de profil
Has already been discussed to death here... Search function "Novo nordisk" and read the posts. There are enough
22
image de profil
@Brateeee the search function here sucks like your comment.
7
image de profil
@Brateeee Thank you! I'm also tired of reading about Novo Nordisk here. There are soooo many other interesting stocks/topics
image de profil
I see that there are obese people all around the world and that there's no " U.S market dependency "
image de profil
@Jo_Wolf they literally make 57% of their revenue in the US. How is that no US market dependency? https://www.marketscreener.com/quote/stock/NOVO-NORDISK-A-S-1412980/finances-segments/
Utilisateur supprimé
1Sem.
Le commentaire a été supprimé
@Allan- French fries hahahhahahahah. I think you need to go back to school
image de profil
@Allan- whether you're right or wrong. You are my bro! 😂😂😂😂 (I have 1000 shares in at the moment. Let's see)
Participez à la conversation